Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease–Ahead Program

Abstract
No abstract available
Funding Information
  • AbbVie
  • AbbVie
  • Amgen
  • Boehringer Ingelheim
  • Celgene
  • Lilly
  • Genentech
  • Gilead
  • Pfizer
  • Merck
  • Prometheus
  • Takeda
  • AbbVie
  • Pfizer
  • Prometheus
  • AbbVie
  • Pfizer
  • Mead Johnson
  • Ferring
  • Merck Sharp & Dohme
  • Johnson & Johnson
  • Merck Sharp & Dohme
  • Danone
  • Mead Johnson
  • Takeda
  • Celgene
  • Shire
  • AbbVie
  • Pfizer
  • ZonMw
  • AbbVie
  • Celgene
  • Gilead
  • Lilly
  • Merck
  • AbbVie
  • AbbVie
  • AbbVie
  • UC